Further studies have indicated that TSPJ prominently suppresses the proliferation of human lung adenocarcinoma A549 cells through mechanisms involving the PI3K/Akt pathway, particularly by modulating PTEN, a known tumor-suppressing factor. Here, AKT1 is linked to neoplasm.